Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradialytic Parenteral Nutrition with Olimel N9 in Hemodialysis Patients
2018-003899-13Phase 4Active
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Olimel N9 in protein-calorie malnutrition (PCM), Sarcopenia and end-stage kidney disease (ESKD). Primary endpoint: Lean tissue mass. Started Nov 2018; status: active.
02
Drugs
Olimel N9
03
Conditions
protein-calorie malnutrition (PCM)Sarcopeniaend-stage kidney disease (ESKD)
Beyond the preview
Go deeper on 2018-003899-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003899-13.